CD8 T Cell Tolerance to a Tumor-Associated Self-Antigen Is Reversed by CD4 T Cells Engineered To Express the Same T Cell Receptor-Reference-Cited by-同舟云学术

CD8 T Cell Tolerance to a Tumor-Associated Self-Antigen Is Reversed by CD4 T Cells Engineered To Express the Same T Cell Receptor

Published:2014-12-24 Issue:3 Volume:194 Page:1080-1089
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Ghorashian Sara,Veliça Pedro,Chua Ignatius,McNicol Anne-Marie,Carpenter Ben,Holler Angelika,Nicholson Emma,Ahmadi Maryam,Zech Mathias,Xue Shao-An,Uckert Wolfgang,Morris Emma,Chakraverty Ronjon,Stauss Hans J.

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference38 articles.

1. Adoptive T cell therapy of cancer

2. Prospects and Limitations of T Cell Receptor Gene Therapy

3. Treating cancer with genetically engineered T cells

4. Immunotherapy with gene-modified T cells: limiting side effects provides new challenges

5. The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD8 is down(regulated) for tolerance;Trends in Immunology;2024-06

2. Novel Cellular Therapies for Hepatocellular Carcinoma;Cancers;2022-01-20

3. T Cell Engaging Immunotherapies, Highlighting Chimeric Antigen Receptor (CAR) T Cell Therapy;Cancers;2021-12-01

4. CRISPR-mediated deletion of the Protein tyrosine phosphatase, non-receptor type 22 (PTPN22) improves human T cell function for adoptive T cell therapy;2020-12-04

5. Breaking Bottlenecks for the TCR Therapy of Cancer;Cells;2020-09-14